Literature DB >> 7523600

3-Nitropropionic acid toxicity in the striatum.

U Wüllner1, A B Young, J B Penney, M F Beal.   

Abstract

We examined the effects of chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) in doses ranging from 12 to 16 mg/kg/day for 30 days on striatal cytoarchitecture in rats. Administration of 3-NP at a dose of 16 mg/kg/day resulted in large lesions with a central necrotic core that was depleted of both neurons and glia. Glial fibrillary acidic protein (GFAP) gene expression was decreased in the lesion core, whereas the tissue surrounding this area showed a massive increase in signal intensity. Enkephalin and substance P mRNA expression in the striatum showed dose-dependent decreases following administration of 3-NP. A substantial decrease occurred even in animals treated with 3-NP at a dose of 12 mg/kg/day, in which there was little discernible neuronal loss and no increase in GFAP gene expression. In contrast to the decrease in enkephalin and substance P mRNA expression, somatostatin mRNA-expressing neurons were largely preserved. There was no preferential loss of [3H]naloxone patches in the rat striatum following chronic administration of 3-NP. In animals treated with 12-15 mg/kg/day neither the area nor binding density of the patches was changed. To study the effect of 3-NP on N-methyl-D-aspartate (NMDA)-gated Ca2+ channels we used in vivo administration of [3H]MK-801. Three hours after a single injection of 3-NP at a dose of 30 mg/kg there was a three- to fivefold increase in [3H]MK-801 binding in cortex and striatum as compared with saline-treated animals, consistent with an activation of NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523600     DOI: 10.1046/j.1471-4159.1994.63051772.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia.

Authors:  Garnik Akopian; Cynthia Crawford; M Flint Beal; Maurand Cappelletti; Michael W Jakowec; Giselle M Petzinger; Ling Zheng; Stacey L Gheorghe; Carmela M Reichel; Robert Chow; John P Walsh
Journal:  J Neurosci       Date:  2008-09-17       Impact factor: 6.167

2.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

3.  Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Authors:  D Pubill; E Verdaguer; A M Canudas; F X Sureda; E Escubedo; J Camarasa; M Pallàs; A Camins
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

4.  Methylmalonyl-CoA mutase induction by cerebral ischemia and neurotoxicity of the mitochondrial toxin methylmalonic acid.

Authors:  P Narasimhan; R Sklar; M Murrell; R A Swanson; F R Sharp
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

5.  Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation.

Authors:  Hyeseung Lee; Robert J Fenster; S Sebastian Pineda; Whitney S Gibbs; Shahin Mohammadi; Jose Davila-Velderrain; Francisco J Garcia; Martine Therrien; Hailey S Novis; Fan Gao; Hilary Wilkinson; Thomas Vogt; Manolis Kellis; Matthew J LaVoie; Myriam Heiman
Journal:  Neuron       Date:  2020-07-17       Impact factor: 17.173

6.  MRS study of glutamate metabolism in cultured neurons/glia.

Authors:  U Sonnewald; L R White; E Odegård; N Westergaard; I J Bakken; J Aasly; G Unsgård; A Schousboe
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

7.  Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.

Authors:  Akram Sidhu; Vishal Diwan; Harsimran Kaur; Deepak Bhateja; Charan K Singh; Saurabh Sharma; Satyanarayana S V Padi
Journal:  Metab Brain Dis       Date:  2018-07-27       Impact factor: 3.584

8.  Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

Authors:  G Akopian; C Crawford; G Petzinger; M W Jakowec; J P Walsh
Journal:  Neuroscience       Date:  2012-04-30       Impact factor: 3.590

9.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Cellular and Subcellular Localization of Endoplasmic Reticulum Chaperone GRP78 Following Transient Focal Cerebral Ischemia in Rats.

Authors:  Xuyan Jin; Dong Kyu Kim; Tae-Ryong Riew; Hong Lim Kim; Mun-Yong Lee
Journal:  Neurochem Res       Date:  2018-05-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.